Ratings Manulife Financial Corporation Nyse

Equities

MFC

CA56501R1064

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
23.47 ^USD	+0.43%		+1.73%	+6.20%

Apr. 26	National Bank Previews Lifecos' Q1, Cuts IAG Q1 Forecast by 5%	MT
Apr. 17	TSX Closer: Market Manages To Finish Up 13 Points After MIdday Plunge	MT

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

The company is in a robust financial situation considering its net cash and margin position.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
With regards to fundamentals, the enterprise value to sales ratio is at 0.8 for the current period. Therefore, the company is undervalued.
The company has a low valuation given the cash flows generated by its activity.
This company will be of major interest to investors in search of a high dividend stock.
Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
Over the past four months, analysts' average price target has been revised upwards significantly.
Over the past twelve months, analysts' opinions have been strongly revised upwards.
The group usually releases upbeat results with huge surprise rates.

Ratings chart - Surperformance

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
MANULIFE FINANCIAL CORPORATION	+6.20%	42.2B	-
METLIFE, INC.	+6.49%	50.92B	B+
AFLAC INCORPORATED	+1.35%	48.11B	B
PRUDENTIAL FINANCIAL, INC.	+6.55%	39.71B	B+
GENERALI	+19.34%	37.78B	B
SUN LIFE FINANCIAL INC.	+2.84%	30.07B	B
GREAT-WEST LIFECO INC.	-7.77%	27.56B	B-
PRUDENTIAL PLC	-18.42%	24.71B	A-
CATHAY FINANCIAL HOLDING CO., LTD.	+6.89%	21.99B	A
DAI-ICHI LIFE HOLDINGS, INC.	+20.69%	21.68B	B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes